The global demand for Positron Emission Tomography Market is presumed to reach the market size of nearly USD 4.44 MN by 2028 from USD 2.8 MN in 2021 with a CAGR of 6.8% under the study period 2022 - 2028.
Positron Emission Tomography or PET is a clinical imaging technology used to diagnose various diseases such as cancer and Alzheimer's. Positron emission tomography (PET) refers to a medical imaging procedure deployed to track the internal organs in a human body in a bid to identify the presence of any disorders. Positron emission tomography uses a radioactive PET tracer, a specific positron emission tomography camera, and a computer to understand the normal and abnormal metabolic activity. PET is used to detect heart disease, brain disorders, and cancer at an early stage.
The growing number of cancer patients worldwide is one of the key reasons for increasing the Positron Emission Tomography (PET) market growth. Moreover, the continuous support for cancer research from the public and private sectors in the form of funds and investments accelerates market growth. Also, the surge in the number of research and development activities to enhance the treatment options available further influence the market. Furthermore, The PET imaging devices market is growing due to its wide range of applications. PET devices detect brain disorders, breast, cervical, colorectal, lung, lymphatic system, pancreatic, prostate, skin, and thyroid cancer, heart disease, cerebrovascular diseases, and epilepsy. However, stringent regulatory rules are expected to obstruct market growth.
The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of positron emission tomography. The growth and trends of positron emission tomography industry provide a holistic approach to this study.
This section of the positron emission tomography market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Detector Type
- Bismuth Germanium Oxide (BGO)
- Lutetium Oxyorthosilicate (LSO)
- Gadolinium Oxyorthosilicate (GSO)
- Lutetium Fine Silicate (Lfs)
- Lutetium Yttrium Orthosilicate (LYSO)
- Diagnostic Centres
- Pet Centres
- Research Institutes
This section covers the regional outlook, which accentuates current and future demand for the Positron Emission Tomography market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Positron Emission Tomography Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the positron emission tomography market include Agfa Healthcare, Gamma Medica Inc., GE Healthcare, Neusoft Medical Systems, Oncovision, Koninklijke Philips N.V., Positron Corporation, Siemens Healthineers AG, Segami Corporation, Spectrum Dynamics Ltd., Naviscan, Inc., MedX Holdings Inc., Modus Medical Devices Inc., Radiology Oncology Systems, Inc., Yangzhou Kindsway Biotech Co. Ltd., Toshiba Corporation, Hitachi, Ltd., Cerveau Technologies, Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
Frequently Asked Questions (FAQs) about this Report
b. In 2021, the global market size for positron emission tomography was worth USD 2.8 Billion.
b. Between 2023 and 2028, the worldwide positron emission tomography market growth is projected to be nearly 6.8%.
b. The global positron emission tomography market is segmented by Application (Oncology, Cardiology, Neurology, Others ), by Detector Type (Bismuth Germanium Oxide (BGO), Lutetium Oxyorthosilicate (LSO), Gadolinium Oxyorthosilicate (GSO), Lutetium Fine Silicate (LFS), Lutetium Yttrium Orthosilicate (LYSO)), by End-User (Hospitals, Diagnostic Centres, PET Centres, Research Institutes).
b. The leading players in the global positron emission tomography market are Agfa Healthcare, Gamma Medica Inc., GE Healthcare, Neusoft Medical Systems, Oncovision, Koninklijke Philips N.V., Positron Corporation, Siemens Healthineers AG, Segami Corporation, Spectrum Dynamics Ltd., Naviscan, Inc., MedX Holdings Inc., Modus Medical Devices Inc., Radiology Oncology Systems Inc., Yangzhou Kindsway Biotech Co. Ltd., Toshiba Corporation, Hitachi Ltd., Cerveau Technologies Inc.